Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Jonathan Sackier, MD, a Visiting Professor of Surgery at the University of Virginia, discusses the incidence and costs of catheter related blood stream infections (CRBSI) in hospitals in…
NEW YORK (Reuters Health) – The percentage of cardiac surgery patients given blood transfusions varies widely from center to center, but a conservative use of transfusions is not…
NEW YORK (Reuters Health) – Deep brain stimulation, of either the globus pallidus or subthalamic nuclei, can provide long-lasting improvement in motor symptoms in many patients with Parkinson’s…
NEW YORK (Reuters Health) – Patients with age-related macular degeneration treated with the anti-VEGF monoclonal antibodies bevacizumab and ranibizumab do not have any higher rates of mortality, MI…
NEW YORK (Reuters Health) – Rofecoxib used as adjuvant therapy does not improve survival or reduce recurrences in patients who have undergone surgery for colorectal cancer, according to…
NEW YORK (Reuters Health) – For women who have undergone laparoscopic surgery for severe endometriosis, ongoing chronic pelvic pain is relieved with use of the levonorgestrel-releasing intrauterine system…
NEW YORK (Reuters Health) – Mortality in acute coronary syndromes is no lower among those taking aspirin before the event than in non-aspirin users. This apparent “aspirin paradox”…
Our co-founder of TheDoctorsChannel.com, David Best, MD, MBA, was at the 1960 NFL World Championship Game, when the Philadelphia Eagles defeated Bart Starr and the Green Bay Packers…
Jonathan Sackier, MD, a Visiting Professor of Surgery at the University of Virginia, discusses the ongoing problem of Catheter Related Blood Stream Infections in hospitals in the United…
NEW YORK (Reuters Health) – There’s a 25% chance that patients with hypersensitivity to cephalosporins will also react to penicillins, a European group reports, but the risk with…
